arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
$267.38 ▲ +1.68 (+0.63%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
71 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
39
Health
Weak
Bearish
auto_awesome

Analytical Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $13.1B
Dividend Yield
Revenue Growth 1.2%
Op. Margin 12.0%
ROIC 3.2%
FCF / Share $0.84
Trailing P/E
Price / Book 4.4x
FCF Yield 0.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$995.83M
↑ +1.2%
Net Income Profit after all expenses
$-14.84M
↑ +94.6%
Operating Margin Operating profit as % of sales
12.0%
↑ +142.2% 30th
FCF / Share Free cash flow per share
$0.84
↓ -75.2%
Long-Term Debt Long-term obligations
$1.63B
↓ -8.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
45
Returns
39
Financial Health
50
Cash Quality
3

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters